We bring the most sensitive biophysical assays to the high-throughput screening world. Our integrated biophysics platform combines lab automation with on-the-fly data analysis, allowing our customers to screen up to a million compounds within weeks, harnessing the power of direct binding assays.

nuantic offers AI-guided lead optimization to biotech and pharma customers developing protein- and peptide-based therapeutics. We're able to optimize affinity, developability and aspects of immunogenicity with outstanding success rates with 10x less effort as compared to traditional methods.

arcoris bio develops next-generation technologies for biomarker detection in research and diagnostics. Its flagship MUSE® platform provides universal, programmable signal amplification to enable highly sensitive and multiplex assays that drive the future of digital pathology.